Abstract:Introduction CRISPR–Cas9 gene editing, leveraging bacterial defense mechanisms, offers precise DNA modifications, holding promise in curing genetic diseases. This review critically assesses its potential, analyzing evidence on therapeutic applications, challenges, and future prospects. Examining diverse genetic disorders, it evaluates efficacy, safety, and limitations, emphasizing the need for a thorough understanding among medical professionals and researchers. Acknowledging its transformative impact, a systematic review is crucial for informed decision-making, responsible utilization, and guiding future research to unlock CRISPR–Cas9's full potential in realizing the cure for genetic diseases. Methods A comprehensive literature search across PubMed, Scopus, and the Web of Science identified studies applying CRISPR–Cas9 gene editing for genetic diseases, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Inclusion criteria covered in vitro and in vivo models targeting various genetic diseases with reported outcomes on disease modification or potential cure. Quality assessment revealed a generally moderate to high risk of bias. Heterogeneity prevented quantitative meta-analysis, prompting a narrative synthesis of findings. Discussion CRISPR–Cas9 enables precise gene editing, correcting disease-causing mutations and offering hope for previously incurable genetic conditions. Leveraging inherited epigenetic modifications, it not only fixes mutations but also restores normal gene function and controls gene expression. The transformative potential of CRISPR–Cas9 holds promise for personalized treatments, improving therapeutic outcomes, but ethical considerations and safety concerns must be rigorously addressed to ensure responsible and safe application, especially in germline editing with potential long-term implications. N.D.K.: Conceptualization, Methodology, Validation, Writing, Editing, Review. All the data used in the study are present within the study itself. No new data were created or analyzed in this study. Not applicable. Not applicable. Article published online: 29 March 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Hope, despair and CRISPR — the race to save one woman's life

Quest to use CRISPR against disease gains ground

CRISPR-Based Therapies: Revolutionizing Drug Development and Precision Medicine

Rare Opportunities: CRISPR/Cas-Based Therapy Development for Rare Genetic Diseases

Next Generation Precision Medicine: CRISPR-mediated Genome Editing for the Treatment of Neurodegenerative Disorders

The realization of CRISPR gene therapy

Prime Editing for Human Gene Therapy: Where Are We Now?

CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future

Advancements in CRISPR-Based Therapies for Genetic Modulation in Neurodegenerative Disorders

Rare genetic disorders in India: Current status, challenges, and CRISPR-based therapy

Move over, CRISPR: RNA-editing therapies pick up steam

Addressing the dark matter of gene therapy: technical and ethical barriers to clinical application

Vector enabled CRISPR gene editing – A revolutionary strategy for targeting the diversity of brain pathologies

CRISPR and Gene Editing: A Game-Changer in Drug Development

The Applications of the CRISPR/Cas9 Gene-Editing System in Treating Human Diseases

CRISPR-Based Gene Editing Techniques in Pediatric Neurological Disorders

CRISPR–Cas9 Gene Editing: Curing Genetic Diseases by Inherited Epigenetic Modifications

CRISPR-Cas9 gene editing technology in human gene therapy: the new realm of medicine

Progress in the application of gene editing technology in cancer treatmentstaking CRISPR as an example

Genome Editing in iPSC-Based Neural Systems: From Disease Models to Future Therapeutic Strategies